Contracts › 75N94022C00005
75N94022C00005: The Purpose of the Chemical Synthesis Facility Is for the Contractor to Synthesize and Purify Chemicals, Chemical Intermediates, Drugs, Steroids, and Anti-Fertility Agents for Further Contraceptive Development By the Government.
Awarded to Regents of the University of Minnesota by National Institutes of Health (NIH).
$3.5Mobligated
$6.3Mpotential value
28 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N94022C00005 |
|---|---|
| Awardee | Regents of the University of Minnesota |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | MN |
| Offers received | 3 |
| Period of performance | 29 September 2022 to 28 September 2027 |
| Potential end | 28 September 2029 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record